The global elastography imaging market is experiencing significant growth, with projections indicating that the industry will ...

Leading medical equipment provider recognized for its 'people-first culture,'empowering working environment supporting hospitalsHOUSTON, TX / ACCESSWIRE / November 11, 2024 / Employees at US Med-Equip ...

Personnel/ContractFormycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard 11.11.2024 / 17:41 CET/CESTThe issuer is ...

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy. Throughout the meetings, world-class ...

New innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS ScotlandFormal NHS Scotland partner InnoScot Health is launching a fresh innovation push with the aim of inspiring ...

Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers - First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

Vienna, Austria – November 11th, 2024 – UpNano GmbH (Vienna, Austria), a leader in high-performance 2-photon polymerization (2PP) 3D printing solutions, has announced the release of the NanoOne green, ...

SAN FRANCISCO, CA / ACCESSWIRE / November 11, 2024 / Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI & coding, patient summaries, and referrals - today announced ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it presented promising data from its ...